Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

M. Diamant; M.A. Nauck; R. Shaginian; J.K. Malone; S. Cleall; M. Reaney; D. de Vries; B.J. Hoogwerf; L. MacConell; B.H.R. Wolffenbuttel

doi:10.2337/dc14-0876

Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

M. Diamant, M.A. Nauck, R. Shaginian, J.K. Malone, S. Cleall, M. Reaney, D. de Vries, B.J. Hoogwerf, L. MacConell, B.H.R. Wolffenbuttel

Internal medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2763-2773
Journal	Diabetes Care
Volume	37
Issue number	10
DOIs	https://doi.org/10.2337/dc14-0876
Publication status	Published - 2014

Access to Document

10.2337/dc14-0876

Cite this

@article{458cbdaa3ff942aab3c13ed57e3f6dd0,

title = "Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes",

author = "M. Diamant and M.A. Nauck and R. Shaginian and J.K. Malone and S. Cleall and M. Reaney and {de Vries}, D. and B.J. Hoogwerf and L. MacConell and B.H.R. Wolffenbuttel",

year = "2014",

doi = "10.2337/dc14-0876",

language = "Undefined/Unknown",

volume = "37",

pages = "2763--2773",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "10",

}

TY - JOUR

T1 - Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

AU - Diamant, M.

AU - Nauck, M.A.

AU - Shaginian, R.

AU - Malone, J.K.

AU - Cleall, S.

AU - Reaney, M.

AU - de Vries, D.

AU - Hoogwerf, B.J.

AU - MacConell, L.

AU - Wolffenbuttel, B.H.R.

PY - 2014

Y1 - 2014

U2 - 10.2337/dc14-0876

DO - 10.2337/dc14-0876

M3 - Article

C2 - 25011946

VL - 37

SP - 2763

EP - 2773

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 10

ER -